Federal contract award
N6523624C8002
TA3 PHASE 1
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | NIWC ATLANTIC |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AC13 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $7.3M |
| Current contract value | $7.3M |
| Potential contract value / ceiling | $26.4M |
| Start date | Nov 17, 2023 |
| Current end date | Sep 30, 2025 |
| Potential end date | Sep 30, 2025 |
| Latest award activity | Sep 26, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 26, 2025 | P00012 | $0 | REALIGNED FUNDING FROM 0001 TO 1001 |
| Jul 11, 2025 | P00011 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE SECTIONS G TEXT AND J-DISTRIBUTION TO CHANGE THE COR FROM KENNETH MCCULLOUGH TO MATTHEW PAHULA. |
| May 12, 2025 | P00010 | $0 | UPDATE DD254 |
| Jan 28, 2025 | P00009 | $362.1K | FULLY FUND CLIN 1001 IN THE AMOUNT OF $362,111.88 |
| Dec 9, 2024 | P00008 | $300.0K | INCREMENTALLY FUND CLIN 1001 IN THE AMOUNT OF $300K AND UPDATE KEY PERSONNEL. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| BAA Coordinator | Contact | CARCOSA@darpa.mil | Source | Feb 24, 2023 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.